Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib-Reference-Cited by-同舟云学术

Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib

Published:2009-02 Issue:1 Volume:189 Page:63-67
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Schafhausen Philippe,Dierlamm Judith,Bokemeyer Carsten,Bruemmendorf Tim H.,Bacher Ulrike,Zander Axel R.,Schnittger Susanne,Hochhaus Andreas

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference11 articles.

1. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha;Bacher;Leukemia,2005

2. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority;Bumm;Blood,2003

3. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells;Deininger;Cancer,2007

4. Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure;Fabarius;Haematologica,2007

5. (2006) Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia;Kovitz;Blood,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute myeloid leukemia developed in Ph− cells with MLL gene amplification in a patient with chronic myelogenous leukemia;Leukemia & Lymphoma;2018-02-23

2. Philadelphia chromosome-negative acute promyelocytic leukemia manifesting after long-term imatinib treatment for chronic myeloid leukemia: a case report and literature review;Annals of Hematology;2018-02-06

3. Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate;Pediatric Blood & Cancer;2015-01-28

4. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis;Leukemia;2012-07-13

5. The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia;Cancer Genetics;2012-03